mDETECT Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2.19M
- Investors
-
14
mDETECT General Information
Description
Developer of a liquid biopsy technology designed to detect rapid cancer progression. The company utilizes DNA-methylation-based liquid biopsy technology to accurately determine the tumor burden in patients to assess therapy response, enabling oncologists to detect and manage metastatic breast cancer.
Contact Information
Website
www.mdetect-inc.comCorporate Office
- 310 Bagot Street
- Kingston, Ontario K7K 3B5
- Canada
Corporate Office
- 310 Bagot Street
- Kingston, Ontario K7K 3B5
- Canada
mDETECT Timeline
mDETECT Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Seed Round | 31-Mar-2026 | $2.19M | Completed | Generating Revenue | ||
| 13. Accelerator/Incubator | 01-Jun-2025 | Completed | Generating Revenue | |||
| 12. Grant | 26-Sep-2024 | Completed | Generating Revenue | |||
| 11. Accelerator/Incubator | 01-Apr-2024 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 01-Dec-2023 | Completed | Generating Revenue | |||
| 9. Angel (individual) | 30-May-2023 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 01-May-2023 | Completed | Generating Revenue | |||
| 7. Grant | 01-Mar-2023 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2023 | $516K | Completed | Generating Revenue | ||
| 5. Grant | 07-Jun-2022 | $5K | $516K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
mDETECT Patents
mDETECT Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026210364-A1 | Detection of methylated ovarian cancer tumor dna | Pending | 31-Mar-2025 | ||
| WO-2026104995-A1 | Detection of methylated lung cancer tumor dna | Pending | 12-Nov-2024 |
mDETECT Signals
mDETECT Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Invest Ottawa | Accelerator/Incubator | |||
| LG | Holding Company | |||
| Federal Economic Development Agency for Southern Ontario | Government | |||
| Ontario Genomics | Accelerator/Incubator | |||
| University of Toronto Entrepreneurship | Accelerator/Incubator |
mDETECT FAQs
-
When was mDETECT founded?
mDETECT was founded in 2022.
-
Where is mDETECT headquartered?
mDETECT is headquartered in Kingston, Canada.
-
What is the size of mDETECT?
mDETECT has 2 total employees.
-
What industry is mDETECT in?
mDETECT’s primary industry is Diagnostic Equipment.
-
Is mDETECT a private or public company?
mDETECT is a Private company.
-
What is mDETECT’s current revenue?
The current revenue for mDETECT is .
-
How much funding has mDETECT raised over time?
mDETECT has raised $2.85M.
-
Who are mDETECT’s investors?
Invest Ottawa, LG, Federal Economic Development Agency for Southern Ontario, Ontario Genomics, and University of Toronto Entrepreneurship are 5 of 14 investors who have invested in mDETECT.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process